To explore these issues, sequencing of TET2 was performed in a cohort of 71 ATLL patients from African origin and suffering from aggressive (acute and lymphoma) or indolent (chronic and smoldering) form of the disease (Table 1). This evidence concerns the gene TET2 and adult T-cell leukemia/lymphoma.